| scholarly article | Q13442814 |
| P50 | author | Richard W. Compans | Q45412816 |
| P2093 | author name string | Lamb RA | |
| Roberts PC | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza A virus | Q834390 |
| P304 | page(s) | 127-137 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation | |
| P478 | volume | 240 |
| Q61449744 | A Comprehensive Review on the Interaction Between the Host GTPase Rab11 and Influenza A Virus |
| Q57798558 | A Defect in Influenza A Virus Particle Assembly Specific to Primary Human Macrophages |
| Q33954072 | A crucial role of N-terminal domain of influenza A virus M1 protein in interaction with swine importin α1 protein |
| Q84854217 | A live bivalent influenza vaccine based on a H9N2 virus strain |
| Q42412926 | A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein |
| Q36731466 | A novel M2e-multiple antigenic peptide providing heterologous protection in mice |
| Q34334185 | A novel method to incorporate bioactive cytokines as adjuvants on the surface of virus particles |
| Q59350368 | A novel type of influenza A virus-derived defective interfering particle with nucleotide substitutions in its genome |
| Q35943682 | A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication |
| Q57112729 | A potential treatment for pandemic influenza using siRNAs targeting conserved regions of influenza A |
| Q41303597 | Abnormal Morphological Vesicles in Influenza A Virus Exposed to Acid pH. |
| Q39938968 | Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks |
| Q33793783 | Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway |
| Q28537670 | Alteration of protein levels during influenza virus H1N1 infection in host cells: a proteomic survey of host and virus reveals differential dynamics |
| Q37574221 | Artificial cells: from basic science to applications |
| Q27863797 | Assembly and budding of influenza virus |
| Q33706147 | Association of influenza virus matrix protein with ribonucleoproteins |
| Q39756727 | Basic residues of the helix six domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by PTAP and YPDL late assembly domain motifs |
| Q39838203 | Budding of filamentous and non-filamentous influenza A virus occurs via a VPS4 and VPS28-independent pathway |
| Q38719035 | Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection. |
| Q37705129 | Cholesterol-binding viral proteins in virus entry and morphogenesis |
| Q28085400 | Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs |
| Q35891196 | Coupling high-throughput genetics with phylogenetic information reveals an epistatic interaction on the influenza A virus M segment |
| Q30374733 | Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems. |
| Q27334559 | Cryotomography of budding influenza A virus reveals filaments with diverse morphologies that mostly do not bear a genome at their distal end |
| Q37840709 | Current strategies for subunit and genetic viral veterinary vaccine development. |
| Q35024034 | Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production |
| Q34444943 | Distribution of surface glycoproteins on influenza A virus determined by electron cryotomography |
| Q21558775 | Dual function of CD81 in influenza virus uncoating and budding |
| Q92639104 | Dysregulation of M segment gene expression contributes to influenza A virus host restriction |
| Q35731299 | Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles. |
| Q27314945 | Electron tomography reveals the steps in filovirus budding |
| Q43478692 | Factors responsible for pathogenicity in chickens of a low-pathogenic H7N7 avian influenza virus isolated from a feral duck. |
| Q34482985 | Filament-producing mutants of influenza A/Puerto Rico/8/1934 (H1N1) virus have higher neuraminidase activities than the spherical wild-type |
| Q40273614 | Filamentous Influenza Viruses. |
| Q35913455 | Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3 |
| Q36276270 | Filamentous influenza virus enters cells via macropinocytosis |
| Q38882756 | Filamentous influenza viruses. |
| Q30489269 | Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase |
| Q89614102 | Filamentous versus Spherical Morphology: A Case Study of the Recombinant A/WSN/33 (H1N1) Virus |
| Q39603298 | Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins |
| Q61798802 | Friend or Foe: The Role of the Cytoskeleton in Influenza A Virus Assembly |
| Q36097986 | Host cell dependence of viral morphology |
| Q28396333 | Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs |
| Q90616787 | Identification of Key Amino Acids in the PB2 and M1 Proteins of H7N9 Influenza Virus That Affect Its Transmission in Guinea Pigs |
| Q27341132 | Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain |
| Q41527395 | Identification of morphological differences between avian influenza A viruses grown in chicken and duck cells. |
| Q30403265 | Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content |
| Q37007016 | In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins |
| Q30376482 | Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge |
| Q33809367 | Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses |
| Q56981340 | Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement |
| Q37743549 | Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes |
| Q30376236 | Influenza vaccines based on virus-like particles |
| Q34913111 | Influenza virus assembly and budding |
| Q45345423 | Influenza virus assembly and budding at the viral budozone. |
| Q34092725 | Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly |
| Q27863777 | Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion |
| Q33826913 | Influenza virus m2 ion channel protein is necessary for filamentous virion formation |
| Q37316167 | Influenza virus morphogenesis and budding |
| Q35872602 | Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein |
| Q56965280 | Kinetic analysis of the influenza A virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces |
| Q58001552 | Life Cell Imaging of mRNA Using PNA FIT Probes |
| Q37896557 | Lung vascular targeting through inhalation delivery: insight from filamentous viruses and other shapes |
| Q35091674 | Morphology of influenza B/Lee/40 determined by cryo-electron microscopy |
| Q36949707 | Mutations at alternative 5' splice sites of M1 mRNA negatively affect influenza A virus viability and growth rate |
| Q45326090 | Mutations in the Influenza A virus M1 protein enhance virus budding to complement lethal mutations in the M2 cytoplasmic tail |
| Q30407078 | Mutations in the membrane-proximal region of the influenza A virus M2 protein cytoplasmic tail have modest effects on virus replication |
| Q40110896 | Native morphology of influenza virions |
| Q30357932 | New vaccines against influenza virus. |
| Q36099007 | Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology. |
| Q38631745 | Palmitoylation contributes to membrane curvature in Influenza A virus assembly and hemagglutinin-mediated membrane fusion |
| Q37333871 | Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence |
| Q37222632 | Protein-lipid interactions critical to replication of the influenza A virus |
| Q30398010 | Reassortment between seasonal and swine-origin H1N1 influenza viruses generates viruses with enhanced growth capability in cell culture |
| Q41918223 | Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients. |
| Q28387722 | Residue 41 of the Eurasian avian-like swine influenza a virus matrix protein modulates virion filament length and efficiency of contact transmission |
| Q39685649 | Restriction of viral replication by mutation of the influenza virus matrix protein |
| Q33754914 | RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology |
| Q40815232 | Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding |
| Q37338776 | Shape effects of filaments versus spherical particles in flow and drug delivery |
| Q90276298 | Single-particle measurements of filamentous influenza virions reveal damage induced by freezing |
| Q45730684 | Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins |
| Q28391423 | Specific residues in the 2009 H1N1 swine-origin influenza matrix protein influence virion morphology and efficiency of viral spread in vitro |
| Q28391618 | Spherical influenza viruses have a fitness advantage in embryonated eggs, while filament-producing strains are selected in vivo |
| Q35666756 | Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology |
| Q55627667 | Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization. |
| Q34132726 | Structural changes in Influenza virus at low pH characterized by cryo-electron tomography |
| Q30495070 | Structural organization of a filamentous influenza A virus |
| Q64096033 | Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface |
| Q39438794 | The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase |
| Q27313335 | The Length of Vesicular Stomatitis Virus Particles Dictates a Need for Actin Assembly during Clathrin-Dependent Endocytosis |
| Q28384333 | The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses |
| Q40576355 | The M1 matrix protein controls the filamentous phenotype of influenza A virus |
| Q28278360 | The Rab11 pathway is required for influenza A virus budding and filament formation |
| Q37123163 | The amphipathic helix of influenza A virus M2 protein is required for filamentous bud formation and scission of filamentous and spherical particles |
| Q34071969 | The cholesterol recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence |
| Q42253255 | The genetics of virus particle shape in equine influenza A virus |
| Q27863808 | The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging |
| Q36933890 | The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding |
| Q44954659 | The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein |
| Q39735600 | The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles. |
| Q33843091 | The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells |
| Q34227618 | The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses |
| Q37136609 | Towards multiscale modeling of influenza infection |
| Q34055348 | Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for production of infectious virus particles |
| Q35960581 | Ultracentrifugation deforms unfixed influenza A virions |
| Q30421558 | Virus-like particles as universal influenza vaccines |
| Q34493909 | YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42 |
Search more.